<DOC>
	<DOCNO>NCT01185158</DOCNO>
	<brief_summary>The purpose study find effect ( good bad ) ZD1839 one 's squamous cell head neck cancer . The research do currently effective treatment exist metastatic ( spread cancer cell one area body another ) recurrent squamous cell cancer head neck . The purpose study find ZD1839 shrink tumor cause tumor stop grow period time .</brief_summary>
	<brief_title>A Phase II Study 250-mg ZD1839 Monotherapy Recurrent Metastatic Both Recurrent Metastatic Squamous Cell Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Gefitinib</mesh_term>
	<criteria>Histologically confirm squamous cell carcinoma head neck incurable surgery radiation Patients must measurable disease , define least e lesion accurately measure one dimension ( longer diameter record ) great equal 20mm conventional technique great equal 10mm compute tomograpy ( CT ) scan . Therapeutic history include Following : No prior EGFRbased therapy recurrent disease No chemotherapy irradiation 28day period precede entry study Eastern Cooperative Oncology Group ( ECOG ) performance Status 02 ( kamofsky &gt; 59 % ) Patients must normal organ marrow function define : leukocyte &gt; 3,000ml absolute neutrophil count 1,500/ml platelet 100,000/ml total bilirubin within normal institutional limit AST ( SGOT ) ALT ( SGPT ) &lt; 2.5 X institutional upper limit normal Creatinine &lt; 1.5 Other coexist malignancy malignancy diagnose within last 5 year exception basal cell carcinoma cervical situ . Concomitant use phenytoin , carbamazepine , barbiturate , rifampicin , phenobarbital , ketoconazole , erythromycin , clarithromycin , atorvastatin , cimetidine , ametidine , amitriptyline , imipramine , verpamil , tamoxifen , chlorpromazine , amiodorone , chloroquine , St. John 's Wort Any unresolved chronic toxicity great CTC grade 2 previous anticancer therapy Incomplete heal previous oncologic major surgery Patients may receive investigational agent History allergic reaction attribute compound similar chemical biologic composition ZD 1839 Uncontrolled intercurrent illness Pregnancy breast feeding ( woman child bear potential</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Larynx</keyword>
	<keyword>Lip</keyword>
	<keyword>Oral Cavity Pharynx</keyword>
</DOC>